摘要
目的:研究β受体阻滞剂治疗甲状腺功能亢进症合并高血压病3级的效果。方法:选择笔者所在医院于2017年4月-2019年5月进行治疗的44例甲状腺功能亢进症合并高血压病3级患者,按照治疗方式不同分为两组,各22例,纳入对象常规予以甲巯咪唑片、贝那普利片治疗,其中对照组配合美托洛尔治疗,研究组配合普萘洛尔治疗,观察两组治疗前后各项指标情况。结果:两组治疗前心率、血压、甲状腺功能、BNP、LVEF差异无统计学意义(P>0.05),治疗后研究组心率、血压、甲状腺功能、BNP均优于对照组,研究组LVEF高于对照组,差异有统计学意义(P<0.05)。结论:对于甲状腺功能亢进症合并高血压病3级患者,可采取普萘洛尔配合治疗,患者血压、心率明显好转,且甲状腺功能有效改善,值得应用。
Objective:To study the effect of two kindsβ-receptor blocker in hyperthyroidism patients with grade 3 of hypertension.Method:Forty-four hyperthyroidism patients with grade 3 of hypertension treated from April 2017 to May 2019 in our hospital were selected.According to different therapies,patients were assigned to two groups,22 cases in patients were enrolled and were routinely treated with Methimazole and Benazepril Tablets on the basis,the control group took Metoprolol;the study group took Propranolol.The clinical indicators were assessed.Result:Before treatment,heart rate,blood pressure,thyroid function,BNP(brain natriuretic peptide)and LVEF(left ventricular ejection fraction)between groups were not significantly different(P>0.05);after treatment,heart rate,blood pressure,thyroid function,LVEF and BNP contents in the study group were better than those in the control group(P<0.05).Conclusion:Propranolol can remarkably improve patients’blood pressure,heart rate and thyroid function.It is worthy of application.
作者
林惠颖
黄焕贤
何建发
陈胜华
李明民
LIN Huiying;HUANG Huanxian;HE Jianfa;CHEN Shenghua;LI Mingmin(Zhongshan Guzhen People’s Hospital,Zhongshan 528421,China)
出处
《中外医学研究》
2019年第35期20-22,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
基金
中山市卫生和计划生育局医学科研项目(项目编号：2017A020176)
